Global Antiepileptic Drugs (AED) Market Size, Share, and COVID-19 Impact Analysis, By Drug Generation (First Generation, Second Generation, Third Generation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Intravenous), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032

Industry: Healthcare
RELEASE DATE Dec 2023
REPORT ID SI3105
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Drug Generation
      2. Market Attractiveness Analysis, By Distribution Channel
      3. Market Attractiveness Analysis, By Route of Administration
      4. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Countless efforts to diminish the problem.
    3. Restraints
      1.  The reliability of medical care
    4. Opportunities
      1. To improve patient symptoms and their quality of life
    5. Challenges
      1. scarcity of antiepileptic drugs
  6. Global Antiepileptic Drugs Market Analysis and Projection, By Drug Generation
    1. Segment Overview
    2. First Generation
    3. Second Generation
    4. Third Generation
  7. Global Antiepileptic Drugs Market Analysis and Projection, By Distribution Channel
    1. Segment Overview
    2. Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
  8. Global Antiepileptic Drugs Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Intravenous
  9. Global Antiepileptic Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Antiepileptic Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Antiepileptic Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   UCB S.A.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Novartis
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Dr. Reddy’s Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   GSK plc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Mylan NV
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. AbbVie
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  H. Lundbeck A/S
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Eisai Co., Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Sanofi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Teva Pharmaceutical Industries
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Sun Pharmaceutical
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Sunovion Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Jazz Pharmaceuticals, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Antiepileptic Drugs Market, By Drug Generation, 2022-203(USD Billion)
  2. Global First Generation, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  3. Global Second Generation, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  4. Global Third Generation, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  5. Global Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  6. Global Hospital Pharmacies, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  7. Global Retail Pharmacies, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  8. Global Online Pharmacies, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  9. Global Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  10. Global Oral, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  11. Global Intravenous, Antiepileptic Drugs Market, By Region, 2022-2032(USD Billion)
  12. North America Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  13. North America Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  14. North America Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  15. U.S.  Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  16. U.S.  Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  17. U.S.  Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  18. Canada Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  19. Canada Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  20. Canada Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  21. Mexico Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  22. Mexico Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  23. Mexico Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  24. Europe Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  25. Europe Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  26. Europe Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  27. Germany Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  28. Germany Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  29. Germany Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  30. France Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  31. France Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  32. France Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  33. U.K.  Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  34. U.K.  Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  35. U.K.  Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  36. Italy Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  37. Italy Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  38. Italy Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  39. Spain Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  40. Spain Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  41. Spain Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  42. Asia Pacific Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  43. Asia Pacific Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  44. Asia Pacific Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  45. Japan Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  46. Japan Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  47. Japan Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  48. China Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  49. China Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  50. China Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  51. India Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  52. India Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  53. India Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  54. South America Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  55. South America Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  56. South America Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  57. Brazil Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  58. Brazil Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  59. Brazil Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  60. The Middle East and Africa Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD   Billion)
  61. The Middle East and Africa Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD   Billion)
  62. The Middle East and Africa Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)
  63. UAE Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  64. UAE Antiepileptic Drugs Market, By Distribution Channel, 2022-2032(USD Billion)
  65. UAE Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion) 
  66. South Africa Antiepileptic Drugs Market, By Drug Generation, 2022-2032(USD Billion)
  67. South Africa Antiepileptic Drugs Market, By Distribution Channel , 2022-2032(USD Billion)
  68. South Africa Antiepileptic Drugs Market, By Route of Administration, 2022-2032(USD Billion)

List of Figures 

  1. Global Antiepileptic Drugs Market Segmentation
  2. Antiepileptic Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Antiepileptic Drugs Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Antiepileptic Drugs Market
  20. Antiepileptic Drugs Market Segmentation, By Drug Generation
  21. Antiepileptic Drugs Market For First Generation, By Region, 2022-2032 ($ Billion)
  22.  Antiepileptic Drugs Market For Second Generation, By Region, 2022-2032 ($ Billion)
  23. Antiepileptic Drugs Market For Third Generation, By Region, 2022-2032 ($ Billion)
  24.  Antiepileptic Drugs Market Segmentation, By Distribution Channel
  25.  Antiepileptic Drugs Market For Hospital Pharmacies, By Region, 2022-2032 ($ Billion)
  26.  Antiepileptic Drugs Market For Retail Pharmacies, By Region, 2022-2032 ($ Billion)
  27. Antiepileptic Drugs Market For Online Pharmacies, By Region, 2022-2032 ($ Billion)
  28. Antiepileptic Drugs Market Segmentation, By Route of Administration
  29. Antiepileptic Drugs Market For Oral, By Region, 2022-2032 ($ Billion)
  30. Antiepileptic Drugs Market For Intravenous, By Region, 2022-2032 ($ Billion)
  31. Pfizer Inc.: Net Sales, 2022-2032 ($ Billion)
  32. Pfizer Inc.: Revenue Share, By Segment, 2022 (%)
  33. Pfizer Inc.: Revenue Share, By Region, 2022 (%)
  34. UCB S.A.: Net Sales, 2022-2032 ($ Billion)
  35. UCB S.A.: Revenue Share, By Segment, 2022 (%)
  36. UCB S.A.: Revenue Share, By Region, 2022 (%)
  37. Novartis: Net Sales, 2022-2032 ($ Billion)
  38. Novartis: Revenue Share, By Segment, 2022 (%)
  39. Novartis: Revenue Share, By Region, 2022 (%)
  40. Dr. Reddy’s Laboratories: Net Sales, 2022-2032 ($ Billion)
  41. Dr. Reddy’s Laboratories: Revenue Share, By Segment, 2022 (%)
  42. Dr. Reddy’s Laboratories: Revenue Share, By Region, 2022 (%)
  43. GSK plc: Net Sales, 2022-2032 ($ Billion)
  44. GSK plc.: Revenue Share, By Segment, 2022 (%)
  45. GSK plc.: Revenue Share, By Region, 2022 (%)
  46. Mylan NV: Net Sales, 2022-2032 ($ Billion)
  47. Mylan NV: Revenue Share, By Segment, 2022 (%)
  48. Mylan NV: Revenue Share, By Region, 2022 (%)
  49. Johnson & Johnson: Net Sales, 2022-2032 ($ Billion)
  50. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  51. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  52. AbbVie: Net Sales, 2022-2032 ($ Billion)
  53. AbbVie: Revenue Share, By Segment, 2022 (%)
  54. AbbVie: Revenue Share, By Region, 2022 (%)
  55. H. Lundbeck A/S.: Net Sales, 2022-2032 ($ Billion)
  56. H. Lundbeck A/S.: Revenue Share, By Segment, 2022 (%)
  57. H. Lundbeck A/S.: Revenue Share, By Region, 2022 (%)
  58. Eisai Co., Ltd.: Net Sales, 2022-2032 ($ Billion)
  59. Eisai Co., Ltd.: Revenue Share, By Segment, 2022 (%)
  60. Eisai Co., Ltd.: Revenue Share, By Region, 2022 (%)
  61. Sanofi: Net Sales, 2022-2032 ($ Billion)
  62. Sanofi: Revenue Share, By Segment, 2022 (%)
  63. Sanofi: Revenue Share, By Region, 2022 (%)
  64. Teva Pharmaceutical Industries: Net Sales, 2022-2032 ($ Billion)
  65. Teva Pharmaceutical Industries: Revenue Share, By Segment, 2022 (%)
  66. Teva Pharmaceutical Industries: Revenue Share, By Region, 2022 (%)
  67. Sun Pharmaceutical: Net Sales, 2022-2032 ($ Billion)
  68. Sun Pharmaceutical: Revenue Share, By Segment, 2022 (%)
  69. Sun Pharmaceutical: Revenue Share, By Region, 2022 (%)
  70. Sunovion Pharmaceuticals Inc.: Net Sales, 2022-2032 ($ Billion)
  71. Sunovion Pharmaceuticals Inc.: Revenue Share, By Segment, 2022 (%)
  72. Sunovion Pharmaceuticals Inc.: Revenue Share, By Region, 2022 (%)
  73. Jazz Pharmaceuticals, Inc.: Net Sales, 2022-2032 ($ Billion)
  74. Jazz Pharmaceuticals, Inc.: Revenue Share, By Segment, 2022 (%)
  75. Jazz Pharmaceuticals, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:115
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:4.3%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies